Joined a co-led €1.5M round for Alcolase, a Danish-British biotech developing an enzyme system that breaks down alcohol before it enters the bloodstream.
Alcolase is developing a liposomal enzyme system designed to break down alcohol in the stomach before it reaches the bloodstream, targeting individuals with alcohol intolerance
Alcolase is developing a liposomal enzyme system designed to break down alcohol in the stomach before it reaches the bloodstream, targeting individuals with alcohol intolerance.